RE:such a shame !Really? Have you even bothered to look at this company's pipeline of prospects? You seem dismissive of the products PLI is bringing to market, such as plasminogen. This has no benifit to patients? Tell that to those who's lives have been changed or saved through the compassionate treatment, or as was the case with the German infant and the emergency treatment to save its life. A product who likely approval is immanent and broad off label use is staggering. This doesn't fit you criteria as being something of benefit? I guess this is all part of your description of 'this company is in the business of being in business while never producing anything substantial'. Give me a break.
You may be frustrated with the pace of progress and the related effect it has had to the share price. Well, welcome to the club. Grow a set of balls, or sell, but do not categorize PLI or PL as as an meaningless company constituted only as a means of enrichment for management. You not only discredit yourself by doing so, but you insult the character of the talented group of professionals PLI has assembled to advance their efforts.
Good luck,
Felco